Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

CommScope Boosts Patents Tally With Fractus Suit Settlement

Published 10/13/2019, 10:08 PM
Updated 07/09/2023, 06:31 AM

CommScope Holding Company, Inc. (NASDAQ:COMM) recently augmented its already impressive patent tally with the acquisition of the base station antenna technology from Fractus SA, thereby amicably settling the pending dispute regarding its use. The buyout is likely to translate into incremental revenues for the company by offering an opportunity to serve a wider spectrum of customers for increased 5G deployment.

Based in Barcelona, Spain, Fractus is one of the pioneering companies that developed internal antennas for smartphones, tablets and wireless IoT devices. It licenses antenna and base station patents developed on indigenous technologies to leading handset and base station antenna manufacturers in the world. The company holds intellectual property rights for more than 40 inventions protected through above 120 patents and patent applications in the United States, Europe and Asia.

Fractus’ base station antenna technology enabled superior operation in multiple frequency bands utilizing a compact design. The CommScope settlement involves the technology transfer for the entire portfolio of Fractus’ base station antenna patents. Notably, CommScope holds about 1,500 patents worldwide on its own, including more than 700 related to base station antenna technology. Consequently, the extensive portfolio of base station antenna systems is likely to help operators improve their network capabilities for increased 5G deployment.

Moving forward, CommScope aims to optimize its excellent customer relationship and competitive position for healthy mobility solutions business, as communication service providers continue to build their networks to increase capacity and coverage. The company remains focused on sound technology, highly efficient supply chain and product improvement. This should make it a preferred partner for all telecommunications businesses as the industry shifts to 5G. With operators moving toward converged or multi-use network structures, combining voice, video and data communications into a single network, the company is actively developing solutions designed to support wireline and wireless network convergence, which is crucial for the success of 5G technology.

CommScope has long-term earnings growth expectation of 16.3%. The stock has lost 31.6% against the industry’s growth of 15.2% in the year-to-date period.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The company is dealing with lower-than-expected performance in the connectivity solutions business. Nevertheless, it is likely to benefit from favorable networking market dynamics and anticipates improving trends through 2019 and beyond, while creating shareholder value.

CommScope currently has a Zacks Rank #3 (Hold). Some better-ranked stocks in the industry are Superconductor Technologies Inc. (NASDAQ:SCON) , Nokia (HE:NOKIA) Corp. (NYSE:NOK) and Zayo Group Holdings, Inc. (NYSE:ZAYO) , each carrying a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Superconductor Technologies surpassed earnings estimates twice in the trailing four quarters, the average surprise being 110.4%.

Nokia surpassed earnings estimates thrice in the trailing four quarters, the average positive surprise being 89.3%.

Zayo delivered average earnings surprise of 4.6% in the trailing four quarters.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



CommScope Holding Company, Inc. (COMM): Free Stock Analysis Report

Zayo Group Holdings, Inc. (ZAYO): Free Stock Analysis Report
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Superconductor Technologies Inc. (SCON): Free Stock Analysis Report

Nokia Corporation (NOK): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.